Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer
HTML
PDF
Details
Locations
Year:
2016
Type:
review
Source:
Cancer Treatment Reviews
DOI:
10.1016/j.ctrv.2016.03.004
Authors:
Sherry X. Yang,
Eric Polley,
Stanley Lipkowitz
Institutions:
National Institutes of Health,
National Cancer Institute,
Center for Cancer Research
Language:
English
Topic:
PI3K/AKT/mTOR signaling in cancer
Subfield:
Molecular Biology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
PI3K/Akt signaling,
PIK3CA mutation,
Akt phosphorylation,
breast cancer,
estrogen receptor-positive breast cancer,
HER2-positive breast cancer,
pathological complete response,
anti-HER2 therapy resistance,
prognosis,
precision medicine,
breast cancer subtypes
show all 11
SDG:
Good health and well-being
Open Access status:
bronze
Funders:
National Institutes of Health,
National Cancer Institute
Award:
Genomic characterization of breast cancer in high risk subsets of breast cancer
OpenAlex ID:
W2295277526
FWCI:
2.8
Cites:
112
Cited by:
249
Related to:
10